1. Home
  2. RELL vs DTIL Comparison

RELL vs DTIL Comparison

Compare RELL & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richardson Electronics Ltd.

RELL

Richardson Electronics Ltd.

N/A

Current Price

$17.79

Market Cap

250.1M

Sector

Technology

ML Signal

N/A

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

N/A

Current Price

$7.47

Market Cap

214.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RELL
DTIL
Founded
1947
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
250.1M
214.7M
IPO Year
2004
2019

Fundamental Metrics

Financial Performance
Metric
RELL
DTIL
Price
$17.79
$7.47
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$45.00
AVG Volume (30 Days)
220.9K
519.6K
Earning Date
04-08-2026
05-14-2026
Dividend Yield
1.75%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$208,909,000.00
$1,070,000,000.00
Revenue This Year
$6.32
N/A
Revenue Next Year
$7.91
N/A
P/E Ratio
$230.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.37
$3.53
52 Week High
$23.15
$9.62

Technical Indicators

Market Signals
Indicator
RELL
DTIL
Relative Strength Index (RSI) 52.27 46.74
Support Level $14.74 $6.30
Resistance Level $18.96 $7.96
Average True Range (ATR) 1.36 0.54
MACD 0.16 -0.18
Stochastic Oscillator 36.92 17.53

Price Performance

Historical Comparison
RELL
DTIL

About RELL Richardson Electronics Ltd.

Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. The company's segment includes Power and Microwave Technologies, Green Energy Solutions, Canvys, and Healthcare. The company generates the majority of its revenue from the Power and Microwave Technologies segment, which includes the power grid and microwave tube business and RF, Wireless and Power technologies.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Share on Social Networks: